Another study reported that inhibiting the expression of Pygo2 could decrease the proliferation, colony formation, and BrdU incorporation of gliomas by reducing cyclin D1, a downstream gene of the Wnt/β-catenin signaling pathway [27]. The gene discussed is PYGO2; the disease is glioma.